About Markus Krankenhaus Klinik für Gynäkologie und Geburtshilfe
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Markus Krankenhaus Klinik für Gynäkologie und Geburtshilfe
During the past decade, Markus Krankenhaus Klinik für Gynäkologie und Geburtshilfe conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Phase 2B Multicenter, Randomized, Comparative Trial Of UK-453,061 Versus Etravirine In Combination With Darunavir/Ritonavir And A Nucleos(t)Ide Reverse Transcriptase Inhibitor For The Treatment Of Antiretroviral Experienced HIV-1 Infected Subjects With Evidence Of NNRTI Resistant HIV-1
2009-03-25
2012-10-18
Terminated
105
Study of Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir in HIV-infected Antiretroviral naïve Subjects
2010-08-01
2013-10-01
Completed
800
Study to Evaluate the Safety and Efficacy of a Single Tablet Regimen of Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Compared With a Single Tablet Regimen of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
2011-02-01
2014-02-01
Completed
799
Safety and Efficacy of E/C/F/TDF Versus RTV-Boosted ATV Plus FTC/TDF in HIV-1 Infected, Antiretroviral Treatment-Naive Women
2012-10-24
2018-09-06
Completed
583
Study to Evaluate the Safety and Efficacy of E/C/F/TAF Versus E/C/F/TDF in HIV-1 Positive, Antiretroviral Treatment-Naive Adults
2013-03-12
2018-10-03
Completed
872
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Markus Krankenhaus Klinik für Gynäkologie und Geburtshilfe"
#1 collaborator was "Hoffmann-La Roche" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Markus Krankenhaus Klinik für Gynäkologie und Geburtshilfe
According to Clinical.Site data, the most researched conditions in "Markus Krankenhaus Klinik für Gynäkologie und Geburtshilfe" are
"Invasive Breast Cancer" (1 trials) and "Invasive Ductal Breast Carcinoma" (1 trials). Many other conditions were trialed in "Markus Krankenhaus Klinik für Gynäkologie und Geburtshilfe" in a lesser frequency.
Clinical Trials Intervention Types at Markus Krankenhaus Klinik für Gynäkologie und Geburtshilfe
Most popular intervention types in "Markus Krankenhaus Klinik für Gynäkologie und Geburtshilfe" are "Drug" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (2 trials), "Surgery" (2 trials), "Abraxane" (1 trials), "Anthra" (1 trials) and "Atezolizumab" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Markus Krankenhaus Klinik für Gynäkologie und Geburtshilfe
The vast majority of trials in "Markus Krankenhaus Klinik für Gynäkologie und Geburtshilfe" are
2 trials for "Female" genders.
Clinical Trials Status at Markus Krankenhaus Klinik für Gynäkologie und Geburtshilfe
Currently, there are NaN active trials in "Markus Krankenhaus Klinik für Gynäkologie und Geburtshilfe".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Markus Krankenhaus Klinik für Gynäkologie und Geburtshilfe,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Markus Krankenhaus Klinik für Gynäkologie und Geburtshilfe, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".